T0	Outcomes 328 337	long-term
T1	Outcomes 349 407	hypothalamic-pituitary-gonadal axis suppression and safety
T2	Outcomes 654 690	showed maintenance of LH suppression
T3	Outcomes 822 924	MEASURES Peak-stimulated LH, estradiol, T, growth rate, pubertal progression, and adverse events (AEs)
T4	Outcomes 1024 1037	had LH values
T5	Outcomes 1104 1126	escaped LH suppression
T6	Outcomes 1145 1182	maintained sex steroid concentrations
T7	Outcomes 1225 1249	of pubertal progression.
T8	Outcomes 1250 1253	AEs
T9	Outcomes 1286 1310	with injection site pain
T10	Outcomes 1350 1355	No AE
T11	Outcomes 1394 1412	The safety profile
T12	Outcomes 1577 1605	an acceptable safety profile
T13	Outcomes 1610 1648	provided maintenance of LH suppression